Advertisement

February 1, 2007

Bipolar Disorder Geodon Weight Loss Study at Stanford University

Geodon in Weight Loss Study for Bipolar Disorders

Stanford University (Palo Alto, California) has just started enrollment for a new research study at the Stanford University Bipolar Disorders Clinic. Here is some information on this study:

Stanford University is examining the use of ziprasidone (Geodon) in the treatment of patients currently experiencing possible weight gain due to use of a mood stabilizer and/or an antipsychotic in Bipolar Disorder. In this study, after an initial evaluation phase, patients will be instructed to replace Geodon for their current stable medication regimen for a period of 12 weeks while being monitored by a psychiatrist using clinical and laboratory measures. For additional information, please contact Kristine Keller at (650) 498-4968.

More information: Stanford University Bipolar Disorders Clinic

Comments

Post a comment


Type the characters you see in the picture above.

Remember Me?
Advertisement